# A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19

> **NCT04433910** · PHASE2 · COMPLETED · sponsor: **Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen** · enrollment: 106 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Convalesscent Plasma

## Key facts

- **NCT ID:** NCT04433910
- **Lead sponsor:** Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-30
- **Primary completion:** 2021-01-21
- **Final completion:** 2022-03-25
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04433910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04433910, "A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04433910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*